-
Blinatumomab, sold
under the
brand name Blincyto, is a
biopharmaceutical medication used for the
treatment of
Philadelphia chromosome-negative relapsed...
- and
clinical trials to ****ess
their therapeutic efficacy and safety.
Blinatumomab links T
cells with CD19
receptors found on the
surface of B cells. The...
- Amgen's next-generation
biomanufacturing facility in Singapore.
Blincyto (
blinatumomab) was
approved by the FDA in
December of that year. Amgen's
Thousand Oaks...
- in immunotherapy,
particularly the use of
monoclonal antibodies like
blinatumomab and
inotuzumab ozogamicin,
which target specific cancer cells and are...
-
animals and can
trigger allergic reactions in humans. An
example is
blinatumomab,
which is used to
treat acute lymphoblastic leukemia.
Chimeric monoclonal...
- (Bristol-Myers Squibb)
bleomycin (INN) Bleph-10 (Allergan)
Blephamide (Allergan)
blinatumomab (USAN, INN) Blis-To-Sol (Oakhurst Company)
Blocadren (Merck) blonanserin...
-
Ipilimumab L01FX05
Brentuximab vedotin L01FX06
Dinutuximab beta L01FX07
Blinatumomab L01FX08
Elotuzumab L01FX09
Mogamulizumab L01FX10
Olaratumab L01FX11 Bermekimab...
-
clinical trials. The
first bispecific antibody to gain
regulatory approval,
blinatumomab,
targets CD19 on B
cells and CD3 on T cells,
leading to the activation...
- (+hyaluronidase)
Avelumab Axatilimab Belantamab mafodotin Bermekimab Blinatumomab Cemiplimab Cosibelimab Daratumumab Dinutuximab beta
Dostarlimab Durvalumab...
- inhibitors, IDH inhibitors, and
monoclonal antibodies such as
inotuzumab and
blinatumomab in the
treatment of ALL. Kantarjian, Hagop; Sawyers, Charles; Hochhaus...
